Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home Coronavirus

Study investigates biochemical, biophysical, and immunological profile of COVID-19 respiratory secretions

by Medical Finance
in Coronavirus
Study: Biochemical, Biophysical, and Immunological Characterization of Respiratory Secretions in Severe SARS-CoV-2 (COVID-19) Infections. Image Credit: GEMINI PRO STUDIO/Shutterstock
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

A recent study posted to the medRxiv* preprint server assessed the biophysical, immunological, and biochemical characteristics of respiratory secretions in acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

Study: Biochemical, Biophysical, and Immunological Characterization of Respiratory Secretions in Severe SARS-CoV-2 (COVID-19) Infections. Image Credit: GEMINI PRO STUDIO/Shutterstock
Study: Biochemical, Biophysical, and Immunological Characterization of Respiratory Secretions in Severe SARS-CoV-2 (COVID-19) Infections. Image Credit: GEMINI PRO STUDIO/Shutterstock

Various studies have highlighted the importance of targeting respiratory secretions to improve coronavirus disease 2019 (COVID-19) clinical outcomes. However, extensive research is needed to understand the characteristics and composition of such secretions for the development of efficient treatment methods.

About the study

The researchers of the present study characterized the elements, rheological properties, and immunological profile of respiratory secretions from COVID-19 patients treated with mechanical ventilation.

The team obtained respiratory secretions from severe COVID-19 patients, aged between five and 70 years. Samples containing respiratory secretions were collected from patients with cystic fibrosis (CF) through spontaneous expectoration and from healthy participants via sputum induction.

Hyaluronan (HA) content of the respiratory secretions was evaluated. The team subsequently stained the samples with HA binding protein (HABP) to examine HA deposits in cadaveric lung sections of severe COVID-19 and CF patients and healthy patients. In addition, they examined the impact of alterations in HA accumulation on the hyaladherins such as versican and tumor necrosis factor-stimulated gene-6 (TSG-6). The double-stranded deoxyribonucleic acid (dsDNA) content was also analyzed in the infected and healthy respiratory secretion samples.

The team assessed lung tissue-specific immune reactions by measuring the levels of 80 cytokines, adhesion molecules, chemokines, and growth factors in the respiratory secretion samples of COVID-19-infected patients and healthy controls.

Results

The study results showed that respiratory samples obtained from healthy patients were generally clear and colorless, whereas those obtained from COVID-19 and CF patients were generally colored and opaque. This indicated that the samples comprised significant amounts of non-soluble debris and biopolymers.

Moreover, the team found that COVID-19 samples contained a substantially higher percentage of solids than healthy samples. Additionally, the protein concentrations observed in COVID-19 samples were almost 5.5 times higher than those in healthy samples. Notably, the protein concentrations were significantly higher in samples infected with COVID-19 and CF compared to samples of controls.

The team observed a 10-fold increase in HA levels in COVID-19 samples as compared to the control samples. Moreover, the average concentration of HA in samples obtained from COVID-19 patients was similar to the concentration in samples from CF patients. The insignificant amounts of HABP staining observed in hyaluronidase (HAdase)-treated samples suggested very low staining of non-specific backgrounds.

However, a noteworthy increase in HA staining was observed in the lung sections obtained from both COVID-19 and CF patients as compared to those from healthy samples, without any prior treatment with HAdase treatment. Overall, the study indicated that severe COVID-19 patients had remarkably higher levels of HA in their lungs. 

In comparison with healthy control respiratory samples, lung sections obtained from both COVID-19 related acute respiratory distress syndrome (ARDS) and non-COVID-19 ARDS patients showed intense staining with HABP treatment in the alveolar-capillary barrier. Moreover, strong heterogeneous staining was observed in diffuse alveolar hemorrhage and distended alveolar-capillary membrane in the COVID-19 lung samples.

Altogether, for both COVID-19-related ARDS and non-COVID-19-related ARDS, there was a trend toward stronger staining of the blood vessels corresponding to the severity of tissue damage.

The respiratory samples obtained from COVID-19 patients showed an average of 14 times higher dsDNA content as compared to that of healthy participants; eight respiratory samples had 10 times higher dsDNA content. However, the average dsDNA concentrations were similar among COVID-19 and CF samples.

Furthermore, a significant decline in levels of antiviral type I interferon-α2 (IFN-α2) and platelet-derived growth factor AA (PDGF-AA) in COVID-19 sputum samples was found as compared to that in healthy controls. In addition, interleukin 13 (IL-13) levels in COVID-19 samples were remarkably different from those of healthy controls.

Various other chemokines and cytokines were significantly upregulated in the COVID-19 samples as compared to healthy controls, including tumor necrosis factor (TNF), IL6, IFNy, IL10, IL1β, IL18, macrophage colony-stimulating factor (M-CSF), RANTES (Regulated Upon Activation, Normal T Cell Expressed, and Secreted).

Conclusion

The study findings showed that the increase in HA and dsDNA levels in COVID-19 ARDS respiratory sputum samples was associated with a higher inflammatory burden in COVID-19. This indicated that DNA and HA may serve as efficient targets for COVID-19 therapy. The researchers believe that the development of treatments that target the respiratory secretions produced in such infections can prove instrumental in improving clinical outcomes of severe COVID-19 and ARDS.

*Important notice

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Study: Covariant Fitness Clusters Reveal Structural Evolution of SARS-CoV-2 Polymerase Across the Human Population. Image Credit: Naeblys/Shutterstock

Analyzing the evolution of SARS-CoV-2 RNA polymerase in humans

by Medical Finance
May 20, 2022
0

A recent work posted by researchers to the bioRxiv* preprint server investigated the evolutionary aspects of severe acute respiratory syndrome...

Study: Demonstration of Hollow Fiber Membrane-Based Enclosed Space Air Remediation for Capture of an Aerosolized Synthetic SARS-CoV-2 Mimic and Pseudovirus Particles. Image Credit: NokkieVector / Shutterstock.com

Hollow fiber membranes efficiently remove synthetic SARS-CoV-2 from the air

by Medical Finance
May 20, 2022
0

Airborne transmission is considered one of the primary factors contributing to the spread of the severe acute respiratory syndrome coronavirus...

Study: Development of the one-step qualitative RT-PCR assay to detect SARS-CoV-2 Omicron (B.1.1.529) variant in respiratory specimens. Image Credit: anyaivanova/Shutterstock

Single-step RT-PCR for SARS-CoV-2 Omicron variant detection in respiratory samples

by Medical Finance
May 20, 2022
0

A new preprint describes a single-step molecular diagnostic test for the presence of severe acute respiratory syndrome coronavirus 2...

Study: Modeling COVID-19 Vaccine Breakthrough Infections in Highly Vaccinated Israel - the effects of waning immunity and third vaccination dose. Image Credit: NEW-LIGHT-VISUALS / Shutterstock.com

Analysis of COVID vaccine breakthrough infections in highly vaccinated Israel

by Medical Finance
May 20, 2022
0

In a recent study published on the medRxiv* preprint server, researchers evaluated and modeled age-structured cases of severe acute respiratory...

Study: T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all prior infected and vaccinated individuals. Image Credit: Puwadol Jaturawutthichai/Shutterstock

Study finds T cell response mostly conserved against SARS-CoV-2 Omicron variant following infection or vaccination

by Medical Finance
May 20, 2022
0

The Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown itself to be a very...

Study: COVID-19 vaccination breakthrough infections in a real-world setting: Using community reporters to evaluate vaccine effectiveness. Image Credit: Srarn Artrattanakul / Shutterstock.com

COVID-19 vaccination breakthrough infections in a real-world setting

by Medical Finance
May 20, 2022
0

The United States Food and Drug Administration (FDA) has authorized three vaccines against coronavirus disease 2019 (COVID-19), all of which...

Next Post
Study: A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune–epithelial interface. Image Credit: MIA Studio/Shutterstock

Researchers investigate SARS-CoV-2 specific inflammatory response

IVM-MS2, “The most compact all-in-one IntraVital two-photon microscopy system in the world”

IVM-MS2, “The most compact all-in-one IntraVital two-photon microscopy system in the world”

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Study: Collaborative modeling key to improving outbreak response. Image Credit: Moab Republic/Shutterstock
    Collaborative modeling attempts could improve response to the COVID-19 pandemic
  • Study: CNBP restricts SARS-CoV2 by regulating IFN and disrupting RNA-protein condensates. Image Credit: NIAID
    SARS-CoV-2 inhibition mediated by cellular nucleic acid-binding protein
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply